Mayne Pharma Group Management
Management criteria checks 2/4
Mayne Pharma Group's CEO is Shawn O’Brien, appointed in Oct 2022, has a tenure of 1.58 years. total yearly compensation is A$1.50M, comprised of 44.2% salary and 55.8% bonuses, including company stock and options. directly owns 0.046% of the company’s shares, worth A$251.90K. The average tenure of the management team and the board of directors is 2.3 years and 2.2 years respectively.
Key information
Shawn O’Brien
Chief executive officer
AU$1.5m
Total compensation
CEO salary percentage | 44.2% |
CEO tenure | 1.6yrs |
CEO ownership | 0.05% |
Management average tenure | 2.3yrs |
Board average tenure | 2.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -AU$274m |
Sep 30 2023 | n/a | n/a | -AU$296m |
Jun 30 2023 | AU$2m | AU$663k | -AU$317m |
Compensation vs Market: Shawn's total compensation ($USD981.61K) is about average for companies of similar size in the Australian market ($USD764.35K).
Compensation vs Earnings: Insufficient data to compare Shawn's compensation with company performance.
CEO
Shawn O’Brien (64 yo)
1.6yrs
Tenure
AU$1,502,156
Compensation
Mr. Shawn Patrick O'Brien, B.Sc has been CEO, MD & Director at Mayne Pharma Group Limited since October 1, 2022. He serves as the Chief Commercial Advisor at Melanovus Oncology, Inc. Mr. O'Brien is a found...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Director | 1.6yrs | AU$1.50m | 0.046% A$ 251.9k | |
Chief Financial Officer | 1.8yrs | AU$1.30m | 0.016% A$ 90.4k | |
Executive VP & General Counsel | 2.3yrs | no data | no data | |
Executive Vice President of Corporate Development | 3.3yrs | AU$1.29m | no data | |
Director of Global Human Resources | 1.3yrs | no data | no data | |
Executive Vice President of Commercial | 4.7yrs | no data | no data | |
Executive VP & Global Chief Medical Officer | 1.3yrs | no data | no data | |
Financial Controller | 19.8yrs | no data | no data | |
Associate General Counsel & Company Secretary | 4.2yrs | no data | no data |
2.3yrs
Average Tenure
Experienced Management: MYX's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, MD & Director | 1.6yrs | AU$1.50m | 0.046% A$ 251.9k | |
Independent Non-Executive Chairman | 6yrs | AU$297.04k | 0.081% A$ 448.3k | |
Independent Non-Executive Director | 9.8yrs | AU$166.43k | 0.039% A$ 215.9k | |
Independent Non-Executive Director | 5.9yrs | AU$212.39k | 0.027% A$ 150.3k | |
Independent Non-Executive Director | 2.2yrs | AU$212.39k | 0.026% A$ 145.2k | |
Independent Non-Executive Director | 2.3yrs | AU$212.42k | 0.047% A$ 258.4k | |
Director | less than a year | no data | no data | |
Independent Non-Executive Director | 1.7yrs | AU$137.96k | no data |
2.2yrs
Average Tenure
62yo
Average Age
Experienced Board: MYX's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.